Canada Life’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Canada Life’s Portfolio SCLN Stock Details SCLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-71,160	Closed	-$793K	–	2608
2017 Q3	$793K	Sell	71,160 -5,411	-7%	-$59.7K	﹤0.01%	1593
2017 Q2	$839K	Buy	76,571 +4,600	+6%	+$46K	﹤0.01%	1574
2017 Q1	$702K	Buy	71,971 +3,739	+5%	+$37.3K	﹤0.01%	1622
2016 Q4	$734K	Hold	68,232	–	–	﹤0.01%	1589
2016 Q3	$698K	Buy	68,232 +3,197	+5%	+$34.8K	﹤0.01%	1572
2016 Q2	$848K	Buy	+65,035	New	+$852K	﹤0.01%	1488

Canada Life's SCLN Position: Q4 2017 in Review

Canada Life sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 71,160 shares — an estimated $793K sold.

Canada Life first reported a position in SCLN in Q2 2016 and held it in 6 quarters. The position peaked at $848K in Q2 2016. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.

Canada Life reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
Canada Life sold 71,160 Sciclone Pharmaceuticals Inc shares in Q4 2017, an estimated $793K.
Canada Life first reported a position in Sciclone Pharmaceuticals Inc in Q2 2016 and held it in 6 quarters.
Canada Life's Sciclone Pharmaceuticals Inc position peaked at $848K in Q2 2016.
0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.

Based on Canada Life's 13F filing for Q4 2017, filed 9 Feb 2018.